In another analysis of 169 patients with epilepsy from Taiwan, a clinically relevant decrease in the maximal rate of metabolism (Vmax) and intrinsic clearance was observed when the patients were CYP2C9 hetero EMs in combination with CYP2C19 hetero EMs or PMs [34]. This evidence concerns the gene CYP2C19 and epilepsy.